Image pharmaphorum Editor News Medical devices ‘linked to deaths and injuries’ claim invest... Medical devices firm Medtronic has been linked to thousands of deaths and injuries, according to a report published by the International Consortium of Investigative Journalists (ICIJ). Disease Spotlight Adaptations and positivity are key to living in the light wi... It took 30 years for Krister Inde to find out the visual impairment that developed when he was 19 was caused by the rare genetic condition LHON. News CEO of UK drugs regulator quits, as Brexit nears The CEO of the UK’s medicine regulator has announced he will leave his post in September next year. News FDA approves Sobi's Gamifant for rare, fatal childhood disea... The FDA has approved Sobi's Gamifant, a treatment for primary hemophagocytic lymphohistiocytosis (HLH). Load more results
News Medical devices ‘linked to deaths and injuries’ claim invest... Medical devices firm Medtronic has been linked to thousands of deaths and injuries, according to a report published by the International Consortium of Investigative Journalists (ICIJ).
Disease Spotlight Adaptations and positivity are key to living in the light wi... It took 30 years for Krister Inde to find out the visual impairment that developed when he was 19 was caused by the rare genetic condition LHON.
News CEO of UK drugs regulator quits, as Brexit nears The CEO of the UK’s medicine regulator has announced he will leave his post in September next year.
News FDA approves Sobi's Gamifant for rare, fatal childhood disea... The FDA has approved Sobi's Gamifant, a treatment for primary hemophagocytic lymphohistiocytosis (HLH).
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
